Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 10,000 shares at $58.03 ($583K) on 2016-08-25, disclosed to the SEC on 2016-08-26.
Open-market sale of $583k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.03 | 7,500 | $435K | 74.7% |
| 2 | $59.02 | 2,500 | $148K | 25.3% |
| Total | $58.28 avg | 10,000 | $583K | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |